Brain Tumours

Lord Polak Excerpts

Monday 24th April 2023 Lords Chamber

[Lord Evans of Rainow (Con)]

I thank the noble Lord and pay my tribute to Tessa Jowell. I remember her final speech in the House. It is one of the most moving speeches I have ever heard; I recommend that noble Lords look it up on YouTube if they missed it first time round.

Brain cancer poses major scientific challenges, requiring investment in basic science through to applied and clinical research. Progress is hard won but we are committed to finding solutions. We want to fund high-quality research to benefit patients. In the four years since the 2018 announcement of £40 million of funding, there have been 13 studies funded by the National Institute for Health and Care Research, with £10.7 million of funding, compared with just six studies in the preceding four years. We want to fund more, but this shows a positive trend.

The department of NIHR continues to work closely with the Tessa Jowell Brain Cancer Mission to grow capacity for brain cancer research. This means attracting new researchers, developing the community and supporting researchers to submit high-quality research funding proposals. As part of this, the Tessa Jowell Brain Cancer Mission will host a round-table event, with cross-party MPs participating to discuss the future of brain tumour research with leaders in the field. I extend an invitation to the noble Lord, Lord Hunt, to attend this meeting, which will be held on 16 May.

[Lord Polak (Con)]

My Lords, I have three interests here. One is that my mother is currently suffering from brain cancer in a hospice in Liverpool. Secondly, I was successfully operated on 35 years ago for a brain tumour. Thirdly, I am an officer of the APPG on Brain Tumours; I was honoured to sit on the inquiry that produced the report, Pathway to a Cure: Breaking Down the Barriers.

In the other place, the Minister, Will Quince, said:

“I understand and share the frustrations that only a proportion of the £40 million on brain tumour research has been allocated”.—[Official Report, Commons, 9/3/23; col. 510.]


Can my noble friend confirm that bureaucracy will not get in the way of releasing funds for research, so that individuals and families who are suffering know that every effort is being made to find a cure for the deadly disease of brain cancer?

[Lord Evans of Rainow (Con)]

I pay tribute to my noble friend and wish his mother well. I was not aware of his fight with brain cancer 35 years ago. We are very lucky to have him in this place—long may it continue.

The NIHR generally does not allocate funding for specific disease areas or ring-fence. The level of research spend in a particular area is decided by factors including scientific potential and the number and scale of successful funding applications. In the four full years since the 2018 announcement of £40 million of funding, a commitment of £10.7 million has been spent on 13 studies, compared with six in the preceding four years. We want to fund more, but this represents a doubling of successful applications. The Government are committed to this but are reliant on good-quality projects being brought forward. I have spoken to my right honourable friend the Minister and more than £40 million will be allocated if the right projects come forward.